Research Interests

• The research group is committed to the study of the pathogenesis and targeted therapy of hematological malignancies. Genomics, transcriptomics, epigenetics, metabonomics, mouse models and other research methods were used to reveal the molecular mechanism of the occurrence and development of hematological malignancies, find potential drug targets and explore targeted therapeutic strategies.